Except: Prescription drug counterfeiters have placed our nation's patients at risk; their criminal actions take advantage of the current patchwork of state laws that could allow venue‐shopping for the best locale in which to expose patients to unsafe and counterfeit prescription drugs.
May 15, 2013 | Letter
To read EPA's May 15, 2013, response, click here.
May 8, 2013 | Letter
April 17, 2013 | Letter
To read a letter signed by the rare disease patient community organizations, click here.
Letter from FDA Commissioner Hamburg on Generic Abuse-Deterrent Formulations of Prescription Opioid ProductsApril 16, 2013 | Letter
April 16, 2013 | Letter
Letters of Support